iShares Genomics Immunology and Healthcare ETF (IDNA)
21.16
-0.34
(-1.57%)
USD |
NYSEARCA |
Jun 13, 16:00
21.17
+0.01
(+0.05%)
After-Hours: 20:00
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.47% | -0.21% | 109.20M | 28263.67 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.85% | 51.00% | -14.20M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of June 15, 2025.
Asset Allocation
As of May 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.41% |
| Stock | 99.54% |
| Bond | 0.05% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of NYSE FactSet Global Genomics and Immuno Biopharma Index. The Fund invests at least 90% of its assets in the components of the Index, which measures the performance of equity securities issued by companies in the biopharmaceutical and healthcare equipment and services. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |